SMI
11.819,24
PKT
-107,87
PKT
-0,90
%
Werbung
Analysen zu SMI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 16.02.22 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 16.02.22 | Roche Buy | Deutsche Bank AG | |
| 14.02.22 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 14.02.22 | UBS Hold | HSBC | |
| 14.02.22 | UBS Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 14.02.22 | Zurich Insurance Buy | UBS AG | |
| 11.02.22 | Roche Neutral | UBS AG | |
| 11.02.22 | UBS Sector Perform | RBC Capital Markets | |
| 11.02.22 | UBS Neutral | UBS AG | |
| 11.02.22 | Zurich Insurance Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 11.02.22 | Roche Buy | Jefferies & Company Inc. | |
| 11.02.22 | UBS Underweight | Barclays Capital | |
| 11.02.22 | UBS Underweight | JP Morgan Chase & Co. | |
| 10.02.22 | UBS Sector Perform | RBC Capital Markets | |
| 10.02.22 | Zurich Insurance Hold | Jefferies & Company Inc. | |
| 10.02.22 | Swiss Re Sell | Goldman Sachs Group Inc. | |
| 10.02.22 | Zurich Insurance Overweight | JP Morgan Chase & Co. | |
| 10.02.22 | UBS Underweight | JP Morgan Chase & Co. | |
| 09.02.22 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 09.02.22 | Novartis Neutral | UBS AG | |
| 09.02.22 | Novartis Equal-weight | Morgan Stanley | |
| 09.02.22 | ABB (Asea Brown Boveri) Equal Weight | Barclays Capital | |
| 09.02.22 | Roche Buy | Deutsche Bank AG | |
| 09.02.22 | Swiss Re Hold | Jefferies & Company Inc. | |
| 08.02.22 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 08.02.22 | Givaudan Neutral | Goldman Sachs Group Inc. | |
| 08.02.22 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 08.02.22 | Swiss Re Underweight | Morgan Stanley | |
| 08.02.22 | Zurich Insurance Equal-weight | Morgan Stanley | |
| 07.02.22 | Holcim Hold | Jefferies & Company Inc. | |
| 07.02.22 | Roche Buy | Deutsche Bank AG | |
| 07.02.22 | ABB (Asea Brown Boveri) Buy | UBS AG | |
| 07.02.22 | Roche Overweight | Barclays Capital | |
| 07.02.22 | Swiss Re Neutral | JP Morgan Chase & Co. | |
| 07.02.22 | Zurich Insurance Overweight | JP Morgan Chase & Co. | |
| 04.02.22 | UBS Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 04.02.22 | Roche Overweight | Barclays Capital | |
| 04.02.22 | Roche Neutral | UBS AG | |
| 04.02.22 | Nestlé Buy | UBS AG | |
| 04.02.22 | ABB (Asea Brown Boveri) Outperform | Bernstein Research |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.